Can the Prophylactic Use of Raloxifene, a Selective Estrogen-Receptor Modulator, Prevent Bone Mineral Loss and Fractures in Women With Diagnosed Osteoporosis or Vertebral Fractures?

Western Journal of Medicine
doi 10.1136/ewjm.173.3.186-a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ